Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #74626 on Innovation Pharmaceuticals Inc (IPIX)
DaubersUP
10/23/14 12:30 PM
#74634 RE: BonelessCat #74626
TOB
#74635 RE: BonelessCat #74626
The bottom line: Based upon the data, Cellceutix has decided that a pivotal Phase 3 trial in 2015 will be for a single-dose of Brilacidin for ABSSSI. -BigKahuna
Phoenix300
10/23/14 12:33 PM
#74642 RE: BonelessCat #74626
cabel
10/23/14 12:34 PM
#74645 RE: BonelessCat #74626
incubus-now
10/23/14 3:14 PM
#74824 RE: BonelessCat #74626